Category: Research

PAC-1, an anti-cancer drug is approved for phase 1(b) clinical trials in humans by the US Food and Drug Administration

Researchers in collaboration with ZIOPHARM Oncology, a biopharmaceutical company announce positive updates on a Phase 1 clinical trials testing a new therapy

Ally is an academic psychiatry trainee, nearly a Consultant psychiatrist, currently funded by The Charity to study non-drug treatments for fatigue in people living with a brain tumour

Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer

Professor Frank Winkler and his team at Heidelberg University in Germany have discovered a potential mechanism that could explain glioma recurrence

Researchers at The Institute of Cancer Research identify new subgroups for high-grade glial tumours occurring in children

Researchers at Stanford University discover that the absence of a particular protein halts the growth of high-grade gliomas

We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma

A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells

Communications Officer, Stephanie Layton, explores the progress of some of the exciting research Dr Darren Hargrave is currently working on.

Researchers have barcoded cancer cells to learn more about growth patterns in hopes of developing more targeted treatments.

This means that 1/2a clinical trials using the drug VBI-1901 can now begin later this year in patients with recurrent GBM. The trials will examine the safety and effectiveness of the drug

Thanks to your continued support and fundraising, we’re delighted to announce that we’ve been able to award over £3.8 million to five new exciting research initiatives across the globe

Researchers have developed ‘nanoswimmers’ that cross the blood brain barrier highly efficiently.

In a new article for Nature Communication, scientists Gelareh Zadeh and Ken Aldape explain that radiation given during childhood cancer treatments causes DNA to rearrange. This rearrangement of DNA can then lead to menigiomas.

Our 2017 Lab Experience is now open! Are you aged 16-17 and interested in lab research? If so, we’d love to hear from you.

Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.

The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body

This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands

The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS

The United States’ Food and Drug Administration (FDA) has approved the use of aminolevulinic acid hydrochloride as an optical imaging agent for use in people affected by high grade gliomas.